Eta-1 gene and methods for use

Details Eta-1 gene and methods for use Eta-1 gene and methods for use

2007-04-17

2007-04-17

Nickol, Gary B (Department: 1646)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S069100, C435S069700, C435S235100, C435S325000, C435S320100, C435S170000, C435S252300, C435S455000, C530S350000

Reexamination Certificate

active

10443910

ABSTRACT:
The present application relates to osteopontin (Eta-1) polypeptides, nucleic acids that encode Eta-1, antibodies that specifically bind to Eta-1, and methods for enhancing an immune response in an animal.

REFERENCES:
patent: 5047237 (1991-09-01), Cochran
patent: 5240703 (1993-08-01), Cochran
patent: 5382425 (1995-01-01), Cochran et al.
patent: 5506128 (1996-04-01), Cochran et al.
patent: 5593873 (1997-01-01), Cochran et al.
patent: 5763269 (1998-06-01), Cochran et al.
patent: 5925358 (1999-07-01), Cochran et al.
patent: 5965138 (1999-10-01), Cochran et al.
patent: 6001369 (1999-12-01), Cochran et al.
patent: 6033904 (2000-03-01), Cochran et al.
patent: 6121043 (2000-09-01), Cochran et al.
patent: 6127163 (2000-10-01), Cochran et al.
patent: 6136318 (2000-10-01), Cochran et al.
patent: WO 90/14092 (1990-11-01), None
patent: WO 91/06666 (1991-05-01), None
patent: WO 91/09955 (1991-07-01), None
patent: WO 94/03628 (1994-02-01), None
patent: WO 95/08622 (1995-03-01), None
patent: WO 98/50069 (1998-11-01), None
patent: WO 00/03030 (2000-01-01), None
patent: WO 00/61736 (2000-10-01), None
patent: WO 00/61773 (2000-10-01), None
Oldberg, et al. PNAS 83:8819-8823, 1986 ‘Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence’.
Hijiya, et al. Biochem. J. 303: 255-262, 1994 ‘Cloning and charcterization of the human osteopontin gene and its promoter’.
MacEwen, EG, Biologics for Cancer Diagnosis, Prevention and Immunotherapy Meeting, Ames, IA, Apr. 12-13, 2001.
Senger, et al, “Transformed Mammalian Cells Secrete Specific Proteins and Phosphoproteins”Cell16:885-893 (1979).
Cole, et al., “The EBV-Hybridoma Technique and Its Application to Human Lung Cancer”Monoclonal Antibodies and Cancer Therapypp. 77-96 (1985).
Ulmer, et al., “Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein”Science259:1745-1749 (1993).
Weber, et al., “Interaction Between CD44 and Osteopontin as a Potential Basis for Metastasis Formation”Proceedings of Association of American Physicians109:1-9 (1997).
Biragyn, et al., “Genetic Fusion of Chemokines to a Self Tumor Antigen Induces Protective, T-cell Dependent Antitumor Immunity”Nature Biotechnology17:253-258 (1999).
Gheradi, et al., “IL-12 delivery from Recombinant Vaccinia Virus Attenuates the Vector and Enhances the Cellular Immune Response Against HIV-1 Env in a Dose-Dependent Manner”The Journal of Immunology162: 6724-6733 (1999).
Vail, et al., “Spontaneously Occuring Tumors of Companion Animals as Models for Human Cancer”Cancer Investigation18:781-792 (2000).
Narvaiza, et al., “Intratumoral Coinjection of Two Adenoviruses, One Encoding the Chemokine IFN- γ-Inducible Protein-10 and Another Encoding IL-12, Results in Marked Antitumoral Synergy”Journal of Immunology164:3112-3122 (2000).
Wu, et al., “Osteopontin is Required for Full Expression of the Transformed Phenotype by theRasOncogene”British Journal of Cancer83:156-163 (2000).
Ashkar, et al., “Eta-1 (Osteopontin): An Entry Component of Type-1 (Cell-Mediated) Immunity”Science287:860-864 (2000).
Kent, et al., “A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques”Vaccine18:2250-2256 (2000).

Affiliated with

Also associated with

Rating

Eta-1 gene and methods for use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Eta-1 gene and methods for use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eta-1 gene and methods for use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3770212